Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus- infected cells

Journal of Experimental Medicine

Volumn 186, Issue 1, 1997, Pages 7-16

  Xu, Xiao Ning ^a,e   Screaton, Gavin R ^a,f   Gotch, Frances M ^b   Dong, Tao ^a   Tan, Rusung ^a   Almond, Neil ^c   Walker, Barry ^c   Stebbings, Richard ^c   Kent, Karen ^c   Nagata, Shigekazu ^d   Stott, Jim E ^c   McMichael, Andrew J ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^c NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^e NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

^f Welcome Trust Arthr Rheumatism C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; NEF PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA DEGRADATION; FLOW CYTOMETRY; MACACA; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS INFECTION; SIMIAN IMMUNODEFICIENCY VIRUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; IMMUNITY, CELLULAR; JURKAT CELLS; MEMBRANE GLYCOPROTEINS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0030744349     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.1.7     Document Type: Article

References (46)

1. Rud, E.W., M. Cranage, J. Yon, J. Quirk, L. Ogilvie, N. Cook, S. Webster, M. Dennis, and B.E. Clarke. 1994. Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J. Gen. Virol. 75:529-543.
2. Daniel, M.D., F. Kirchhoff, S.C. Czajak, P.K. Sehgal, and R.C. Desrosiers. 1992. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science (Wash. DC). 258:1938-1941.
3. Deacon, N.J., A. Tsykin, A. Solomon, K. Smith, M. Ludford Menting, D.J. Hooker, D.A. McPhee, A.L. Greenway, A. Ellett, C. Chatfield et al. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science (Wash. DC). 270:988-991.
4. Almond, N., K. Kent, M. Cranage, E. Rud, B. Clarke, and E.J. Stott. 1995. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet. 345:1342-1344.
5. Rowland-Jones, S., R. Tan, and A. McMichael. 1997. The role of cellular immunity in protection against HIV infection. Adv. Immunol. In press.
6. Yasutomi, Y., K.A. Reimann, C.I. Lord, M.D. Miller, and N.L. Letvin. 1993. Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys. J. Virol. 67:1707-1711.
7. Koup, R.A., J.T. Safrit, Y. Cao, C.A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D.D. Ho. 1994. Temporal association of cellular immune responses with initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
8. Borrow, P., H. Lewicki, B.H. Hahn, G.M. Shaw, and M.B. Oldstone. 1994. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68: 6103-6110.
9. Carmichael, A., X. Jin, P. Sissons, and L. Borysiewicz. 1993. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249-256.
10. Roederer, M., J.G. Dubs, M.T. Anderson, P.A. Raju, L.A. Herzenberg, and L.A. Herzenberg. 1995. CD8 naive T cell counts decrease progressively in HIV-infected adults. J. Clin. Invest. 95:2061-2066.
11. Rinaldo, C.J., L.A. Beltz, X.L. Huang, P. Gupta, Z. Fan, and D.R. Torpey. 1995. Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men. Aids Res. Hum. Retroviruses. 11:481-489.
12. Pantaleo, G., C. Graziosi, and A.S. Fauci. 1993. The immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 328:327-335.
13. Finkel, T.H., and N.K. Banda. 1994. Indirect mechanisms of HIV pathogenesis: how does HIV kill T cells? Curr. Opin. Immunol. 6:605-615.
14. Zinkernagel, R.M., and H. Hengartner. 1994. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol. Today. 15:262-268.
15. Nardelli, B., C.J. Gonzalez, M. Schlechter, and F.T. Valentine. 1995. CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells. Proc. Natl. Acad. Sci. USA. 92:7312-7316.
16. Ameisen, J.C. 1992. Programmed cell death and AIDS: from hypothesis to experiment. Immunol. Today. 13:388-391.
17. Estaquier, J., T. Idziorek, F. de Bels, F. Barre Sinoussi, B. Hurtrel, A.M. Aubertin, A. Venet, M. Mehtali, E. Muchmore, P. Michel et al. 1994. Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc. Natl. Acad. Sci. USA. 91:9431-9435.
18. Meyaard, L., S.A. Otto, R.R. Jonker, M.J. Mijnster, R.P. Keet, and F. Miedema. 1992. Programmed death of T cells in HIV-1 infection. Science (Wash. DC). 257:217-219.
19. Finkel, T.H., G. Tudor Williams, N.K. Banda, M.F. Cotton, T. Curiel, C. Monks, T.W. Baba, R.M. Ruprecht, and A. Kupfer. 1995. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes. Nature. Med. 1:129-1134.
20. Chinnaiyan, A.M., K. Orourke, G.L. Yu, R.H. Lyons, M. Garg, D.R. Duan, L. Xing, R. Gentz, J. Ni, and V.M. Dixit. 1996. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science (Wash. DC). 274:990-992.
21. Kitson, J., T. Raven, Y.-P. Jiang, D.V. Goeddel, K.M. Giles, K.-T. Pun, C.J. Grinham, R. Brown, and S.N. Farrow. 1996. A death-domain-containing receptor that mediates apoptosis. Nature (Lond.). 384:372-375.
22. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science (Wash. DC). 267:1449-1456.
23. Lynch, D.H., F. Ramsdell, and M.R. Alderson. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today. 16:569-574.
24. Abbas, A.K. 1996. Die and let live: eliminating dangerous lymphocytes. Cell. 84:655-657.
25. Nagata, S. 1996. Fas ligand and immune evasion. Nature. Med. 2:1306-1307.
26. Katsikis, P.D., E.S. Wunderlich, C.A. Smith, L.A. Herzenberg, and L.A. Herzenberg. 1995. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181: 2029-2036.
27. Silvestris, F., P. Cafforio, M.A. Frassanito, M. Tucci, A. Romito, S. Nagata, and F. Dammacco. 1996. Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis. AIDS (Phila.). 10:131-141.
28. Tanaka, M., T. Suda, K. Haze, N. Nakamura, K. Sato, F. Kimura, K. Motoyoshi, M. Mizuki, S. Tagawa, S. Ohga et al. 1996. Fas ligand in human serum. Nature. Med. 2:317-322.
29. Tanaka, M., T. Suda, T. Takahashi, and S. Nagata. 1995. Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO (Eur. Mol. Biol. Organ.) J. 14: 1129-3115.
30. Gotch, F.M., R. Hovell, M. Delchambre, P. Silvera, and A.J. Mcmichael. 1991. Cytotoxic T-cell response to simian immunodeficiency virus by cynomolgus macaque monkeys immunized with recombinant vaccinia virus. AIDS (Phila.). 5: 317-320.
31. Herrmann, M., H.-M. Lorenz, R. Voll, M. Grunke, W. Woith, and J.R. Kalden. 1994. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res. 22:5506-5507.
32. Lewis, D.E., D.S. Tang, A. Adu Oppong, W. Schober, and J.R. Rodgers. 1994. Anergy and apoptosis in CD8+ T cells from HIV-infected persons. J. Immunol. 153:412-120.
33. Alderson, M.R., T.W. Tough, T. Davis Smith, S. Braddy, B. Falk, K.A. Schooley, R.G. Goodwin, C.A. Smith, F. Ramsdell, and D.H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71-77.
34. Agy, M.B., K. Foy, M.J. Gale, R.E. Benveniste, E.A. Clark, and M.G. Katze. 1991. Viral and cellular gene expression in CD4+ human lymphoid cell lines infected by the simian immunodeficiency virus, SIV/Mne. Virology. 183:170-180.
35. Cohen, D.I., Y. Tani, H. Tian, E. Boone, L.E. Samelson, and H.C. Lane. 1992. Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus 1. Science (Wash. DC). 256:542-545.
36. Groux, H., G. Torpier, D. Monte, Y. Mouton, A. Capron, and J.C. Ameisen. 1992. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175:331-340.
37. Gallimore, A., M. Cranage, N. Cook, N. Almond, J. Bootman, E. Rud, P. Silvera, M. Dennis, T. Corcoran, J. Stott et al. 1995. Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nature. Med. 1:1167-1173.
38. Griffith, T.S., X.H. Yu, J.M. Herndon, D.R. Green, and T.A. Ferguson. 1996. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity. 5:7-16.
39. Bellgrau, D., D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R.C. Duke. 1995. A role for CD95 ligand in preventing craft rejection. Nature (Lond.). 377:630-632.
40. Hahne, M., D. Rimoldi, M. Schroter, P. Romero. M. Schreier, L.E. French, P. Schneider, T. Bornand, A. Fontana, D. Lienard et al. 1996. Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science (Wash. DC). 274:1363-1366.
41. Strand, S., W.J. Hofmann, H. Hug, M. Muller, G. Otto, D. Strand, S.M. Mariani, W. Stremmel, P.H. Krammer, and P.R. Galle. 1996. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells-A mechanism of immune evasion. Nature. Med. 2:1361-1366.
42. Badley, A.D., J.A. McElhinny, P.J. Leibson, D.H. Lynch, M.R. Alderson, and C.V. Paya. 1996. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 70:199-206.
43. Westendorp, M.O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K.M. Debatin, and P.H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature (Lond.). 375:497-500.
44. Mitra, D., M. Steiner, D.H. Lynch, L. Staiano Coico, and J. Laurence. 1996. HIV-1 upregulates Fas ligand expression in CD4+ T cells in vitro and in vivo: association with Fas-mediated apoptosis and modulation by aurintncarboxylic acid. Immunology. 87:581-585.
45. Trono, D. 1995. HIV accessory proteins: leading roles for the supporting cast. Cell. 82:189-192.
46. Lee, C.-H., K. Saksela, U.A. Mirza, B.T. Chait, and J. Kuriyan. 1996. Crystal structure of the conserved core of HIV-1 nef complexed with a Src family SH3 domain. Cell. 85:931-942.